Zhitong Finance App News, Livingzhu Group (000513.SZ) issued an announcement. Recently, Shanghai Lizhu Pharmaceutical Co., Ltd., the holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” (certificate number: 2024B04743) approved and issued by the State Drug Administration. The injectable leuprorelin acetate microspheres produced by Shanghai Lizhu Pharmaceutical Co., Ltd. passed a consistent evaluation of the quality and efficacy of injectable generic drugs.

Zhitongcaijing · 10/15 11:09
Zhitong Finance App News, Livingzhu Group (000513.SZ) issued an announcement. Recently, Shanghai Lizhu Pharmaceutical Co., Ltd., the holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” (certificate number: 2024B04743) approved and issued by the State Drug Administration. The injectable leuprorelin acetate microspheres produced by Shanghai Lizhu Pharmaceutical Co., Ltd. passed a consistent evaluation of the quality and efficacy of injectable generic drugs.